VEON (VEON) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.59
- EPS estimate
- $1.46
- EPS surprise
- +8.90%
- Revenue surprise
- −0.54%
- Revenue
- $1.2B
- Revenue estimate
- $1.2B
- Reported
- Jul 31, 2026
VEON reported Q2 2026 results on July 31, 2026. EPS was $1.59, above the $1.46 estimate by 8.90%. Revenue was about $1.2 billion, 0.54% below the consensus. A year earlier, Q2 2025 showed EPS of $8.30 on about $1.1 billion of revenue. That Q2 2025 figure is the highest EPS in the table by a wide margin.
The record is uneven. The table jumps from Q3 2021 to Q1 2023 and then to Q2 2024, two rows carry no estimate, and one has no valid report date. Results have swung widely. VEON posted losses of $2.03 per share in Q3 2025 and $0.44 in Q4 2025, then returned to profit with $1.39 in Q1 2026. The four quarters of 2025 add up to $7.23 per share. Quarterly revenue was about $1.7 billion to $2.1 billion in 2020 and 2021, and between about $1.0 billion and $1.2 billion since Q2 2024. Of the 15 quarters with an estimate, VEON beat 9 times, missed 4 and matched 2.
VEON reported Q3 results on November 14, 2024 and November 10, 2025. That points to mid-November 2026 for the next report. It will show whether EPS stays positive.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $1.46 | $1.59 | +8.90% | $1.2B | SEC |
| Q1 2026 | May 13, 2026 | $0.99 | $1.39 | +40.40% | $1.2B | SEC |
| Q4 2025 | Mar 13, 2026 | $1.10 | −$0.44 | −140.00% | $1.2B | SEC |
| Q3 2025 | Nov 10, 2025 | −$2.61 | −$2.03 | +22.41% | $1.1B | SEC |
| Q2 2025 | Aug 7, 2025 | $0.95 | $8.30 | +773.68% | $1.1B | SEC |
| Q1 2025 | May 15, 2025 | $0.83 | $1.40 | +68.67% | $1.0B | SEC |
| Q4 2024 | Mar 20, 2025 | $0.77 | $1.14 | +48.05% | $998.0M | SEC |
| Q3 2024 | Nov 14, 2024 | $0.57 | $2.95 | +417.54% | $1.0B | SEC |
| Q2 2024 | Aug 8, 2024 | $0.00 | $0.96 | +0.00% | $1.0B | SEC |
| Q1 2023 | May 4, 2023 | $0.00 | $0.01 | +0.00% | $884.0M | SEC |
| Q3 2021 | Oct 28, 2021 | $2.75 | $1.50 | −45.45% | $2.0B | — |
| Q2 2021 | Aug 30, 2021 | $1.74 | $1.42 | −18.61% | $2.0B | — |
| Q1 2021 | Invalid Date | $1.75 | $1.75 | +0.00% | $2.0B | — |
| Q4 2020 | Mar 15, 2021 | $1.10 | $1.50 | +36.71% | $2.0B | — |
| Q3 2020 | Oct 29, 2020 | $1.17 | −$3.18 | −371.84% | $1.7B | — |
| Q2 2020 | Aug 6, 2020 | $0.19 | $1.00 | +436.77% | $1.9B | — |
| Q1 2020 | May 7, 2020 | $1.50 | $1.50 | +0.00% | $2.1B | — |
Quarterly revenue
Frequently asked questions
When did VEON (VEON) last report earnings?
VEON last reported on Jul 31, 2026, covering fiscal Q2 2026.
Did VEON beat earnings estimates?
Yes. VEON reported EPS of $1.59 for Q2 2026 against a $1.46 estimate — a 8.90% beat.
How much revenue did VEON report last quarter?
VEON reported $1.2B in revenue for Q2 2026, against a consensus estimate of $1.2B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.